Plain-English translation of NCT04916210 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observational study that enrolls 8,000 people hospitalized with a recent stroke (either bleeding or blockage in the brain). Researchers will follow participants over time with memory tests, brain imaging, and blood work to understand how strokes affect thinking and memory skills, and to discover biological markers that might help predict who is at risk for cognitive decline after a stroke.
Many stroke survivors experience problems with memory and thinking that can be missed or misunderstood. This study aims to identify early warning signs and biological markers in the blood that could help doctors predict and prevent cognitive decline after stroke.
You likely qualify if…
You likely don't qualify if…
You will have an initial visit within 6 weeks of your stroke where you'll provide blood samples and complete memory and thinking tests. You'll then return for in-person follow-up visits at 3–6 months and 18 months, with annual phone check-ins after that. Depending on which tier you're enrolled in, you may receive brain MRI scans or specialized imaging (PET scans) to look for markers of cognitive changes. The study continues for the duration you're able to participate.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States